Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

Gradient Denervation Technologies, a company that makes an ultrasound device for PH, will join an FDA program to speed device ...

A fall and subsequent injury left columnist Jen Cueva with lots of downtime to ponder self-care and the importance of ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment ...

Beyond Air has submitted a supplement application for its second-generation LungFit PH 2 device for treating PPHN.